Characteristics | Total (n = 167) | URG4 | Chi-square test P-value | Fisher’s exact test P-value | ||
---|---|---|---|---|---|---|
Low expression | High expression | |||||
(%) | (%) | |||||
Age (y) | ≥42 | 93 | 56 (60.2) | 37 (39.8) | 0.798 | 0.873 |
<42 | 74 | 46 (62.2) | 28 (37.8) | |||
Clinical stage | Ib1 | 68 | 57 (83.8) | 11 (16.2) | 0.000 | 0.000 |
Ib2 | 59 | 32 (54.2) | 27 (45.8) | |||
IIa1 | 38 | 19 (50.0) | 19 (50.0) | |||
IIa2 | 2 | 0 (0.0) | 2 (100.0) | |||
T classification | T1b1 | 113 | 74 (65.5) | 39 (34.5) | 0.005 | 0.003 |
T1b2 | 39 | 26 (66.7) | 13 (33.3) | |||
T2a | 9 | 1 (11.1) | 8 (88.9) | |||
T2b | 4 | 1 (25.0) | 3 (75.0) | |||
T4 | 2 | 0 (0.0) | 2 (100.0) | |||
N classification | N 0 | 140 | 91 (65.0) | 49 (35.0) | 0.001 | 0.002 |
N 1 | 27 | 11 (40.7) | 16 (59.3) | |||
M classification | Yes | 7 | 4 (57.1) | 3 (42.9) | 0.827 | 1.000 |
No | 160 | 98 (61.2) | 62 (38.8) | |||
Histological differentiation | Well | 8 | 7 (87.5) | 1 (12.5) | 0.058 | 0.069 |
Moderate | 66 | 34 (51.5) | 32 (48.5) | |||
Poor | 93 | 61 (65.6) | 32 (34.0) | |||
Expression of SCC | ≤1.5 | 97 | 64 (66.0) | 33 (34.0) | 0.289 | 0.291 |
>1.5 | 51 | 27 (52.9) | 22 (47.1) | |||
None | 19 | 11 (57.9) | 7 (42.1) | |||
Tumour size, cm | <4 | 106 | 76 (71.7) | 30 (28.3) | 0.012 | 0.018 |
≥4 | 61 | 32 (52.5) | 29 (47.5) | |||
Histological type | Squamous cell carcinoma | 153 | 92 (60.1) | 61 (39.9) | 0.407 | 0.569 |
Adeno cell carcinoma | 14 | 10 (71.4) | 4 (28.6) | |||
Deep stromal invasion | Yes | 100 | 55 (55.0) | 45 (45.0) | 0.123 | 0.139 |
No | 67 | 47 (70.1) | 20 (29.9) | |||
Lymphovascular space involvement | Yes | 7 | 3 (42.9) | 4 (57.1) | 0.312 | 0.433 |
No | 160 | 99 (61.9) | 61 (38.1) | |||
Positive parametrium | Yes | 5 | 2 (40.0) | 3 (60.0) | 0.326 | 0.378 |
No | 162 | 100 (61.7) | 62 (38.3) | |||
Vaginal involvement | Yes | 10 | 1 (10.0) | 9 (90.0) | 0.002 | 0.004 |
No | 157 | 101 (64.3) | 56 (35.7) | |||
Positive surgical margin | Yes | 3 | 1 (33.3) | 2 (66.7) | 0.320 | 0.561 |
No | 164 | 101 (61.6) | 63 (38.4) |